Prostate Clinical Trials Search

Current State: NCT ID:
Return to Map
TitleStateStatusNCT ID
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone MetastasesSouth CarolinaRecruitingNCT00079001
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate CarcinomaSouth CarolinaRecruitingNCT00132301
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesSouth CarolinaRecruitingNCT00377156
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate CancerSouth CarolinaRecruitingNCT00430183
Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate CancerSouth CarolinaRecruitingNCT00499408
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising PSA After Surgery for Prostate CancerSouth CarolinaRecruitingNCT00567580
Salvage Cryotherapy in Recurrent Prostate CancerSouth CarolinaRecruitingNCT00824928
Study of Immunotherapy to Treat Advanced Prostate CancerSouth CarolinaRecruitingNCT00861614
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone MetastasesSouth CarolinaRecruitingNCT00874211
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation TherapySouth CarolinaRecruitingNCT00925600
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerSouth CarolinaRecruitingNCT00936390
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract CancerSouth CarolinaRecruitingNCT00942331
Vitamin D Supplementation in Veterans With Early-Stage Prostate CancerSouth CarolinaRecruitingNCT00953225
Phase 3 Study of Immunotherapy to Treat Advanced Prostate CancerSouth CarolinaRecruitingNCT01057810
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and NeckSouth CarolinaRecruitingNCT01059643
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate CancerSouth CarolinaRecruitingNCT01120236
Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 in Castration-Resistant Prostate Cancer (CRPC)South CarolinaRecruitingNCT01171898
Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate CancerSouth CarolinaRecruitingNCT01188187
Study Comparing Orteronel Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate CancerSouth CarolinaRecruitingNCT01193257
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)South CarolinaRecruitingNCT01194960
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate CancerSouth CarolinaRecruitingNCT01212991
Study of Abiraterone Acetate in Patients With Advanced Prostate CancerSouth CarolinaAvailableNCT01217697
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate CancerSouth CarolinaRecruitingNCT01234311
Saracatinib in Treating Patients With Prostate CancerSouth CarolinaRecruitingNCT01267266
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate CancerSouth CarolinaRecruitingNCT01288911
A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.South CarolinaRecruitingNCT01302054
A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of FesoterodineSouth CarolinaRecruitingNCT01302067
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate CancerSouth CarolinaRecruitingNCT01306890
Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone TherapySouth CarolinaRecruitingNCT01309672
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific AntigenSouth CarolinaRecruitingNCT01314118
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate CancerSouth CarolinaRecruitingNCT01368588
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate CancerSouth CarolinaRecruitingNCT01415960
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate CancerSouth CarolinaRecruitingNCT01431391
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate CancerSouth CarolinaRecruitingNCT01491971
Radium-223 Chloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone MetastasesSouth CarolinaAvailableNCT01516762
PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder TumorsSouth CarolinaNot yet recruitingNCT01567462
Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate CancerSouth CarolinaRecruitingNCT01620515
Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapySouth CarolinaAvailableNCT01606982
A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone AcetateSouth CarolinaRecruitingNCT01517802